Form D Explorer

Form C — Genomic Expression, Inc.

0001665160-24-001361 · filed 2024-10-01 · via StartEngine Capital, LLC

Offering

Target: $15,000
Maximum: $1,235,000
Security type: Other
Price per security: —
Deadline: —
Oversubscription: Accepted

Issuer

Name: Genomic Expression, Inc.
CIK: 1611868
Entity: Corporation
Jurisdiction: DE
Address: 100 CUMMINGS CENTER, SUITE 451C,
BEVERLY, MA 01915
Phone: —

Most recent fiscal year financials

Total assets

$1,076,741

Cash

—

Short-term debt

$201,198

Long-term debt

$337,217

Revenues

$608,380

COGS

$236,708

Taxes paid

—

Net income

$-127,064

View original on SEC EDGAR.